Selected research
Industry Research
Nanotechnology-based Drug Delivery Industry Research Report 2026
Market perspective
The global Nanotechnology-based Drug Delivery market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Nanotechnology-based Drug Delivery market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Nanotechnology-based Drug Delivery market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Nanotechnology-based Drug Delivery market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Nanotechnology-based Drug Delivery include AbbVie Inc., BlueWillow Biologics Inc., Camurus AB, Celgene, lnc., Cristal Therapeutics, EyePoint Pharmaceuticals and Johnson and Johnson, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Nanotechnology-based Drug Delivery market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Nanotechnology-based Drug Delivery.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Nanotechnology-based Drug Delivery Market by Company
AbbVie Inc.
BlueWillow Biologics Inc.
Camurus AB
Celgene, lnc.
Cristal Therapeutics
EyePoint Pharmaceuticals
Johnson and Johnson
Nanotechnology-based Drug Delivery Segment by Type
Nanocrystals
Nanoparticles
Liposomes
Micelles
Others
Nanotechnology-based Drug Delivery Segment by Application
Hospital
Research Institute
Others
Nanotechnology-based Drug Delivery Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nanotechnology-based Drug Delivery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nanotechnology-based Drug Delivery and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nanotechnology-based Drug Delivery.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Nanotechnology-based Drug Delivery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Nanocrystals
- Nanoparticles
- Liposomes
- Micelles
- Others
Applications
- Hospital
- Research Institute
- Others
Companies covered
- AbbVie Inc.
- BlueWillow Biologics Inc.
- Camurus AB
- Celgene, lnc.
- Cristal Therapeutics
- EyePoint Pharmaceuticals
- Johnson and Johnson
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Nanotechnology-based Drug Delivery by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Nanocrystals
- 2.2.3 Nanoparticles
- 2.2.4 Liposomes
- 2.2.5 Micelles
- 2.2.6 Others
- 2.3 Nanotechnology-based Drug Delivery by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Research Institute
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Nanotechnology-based Drug Delivery Breakdown Data by Type
- 3.1 Global Nanotechnology-based Drug Delivery Historic Market Size by Type (2021-2026)
- 3.2 Global Nanotechnology-based Drug Delivery Forecasted Market Size by Type (2027-2032)
4 Nanotechnology-based Drug Delivery Breakdown Data by Application
- 4.1 Global Nanotechnology-based Drug Delivery Historic Market Size by Application (2021-2026)
- 4.2 Global Nanotechnology-based Drug Delivery Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Nanotechnology-based Drug Delivery Market Perspective (2021-2032)
- 5.2 Global Nanotechnology-based Drug Delivery Growth Trends by Region
- 5.2.1 Global Nanotechnology-based Drug Delivery Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Nanotechnology-based Drug Delivery Historic Market Size by Region (2021-2026)
- 5.2.3 Nanotechnology-based Drug Delivery Forecasted Market Size by Region (2027-2032)
- 5.3 Nanotechnology-based Drug Delivery Market Dynamics
- 5.3.1 Nanotechnology-based Drug Delivery Industry Trends
- 5.3.2 Nanotechnology-based Drug Delivery Market Drivers
- 5.3.3 Nanotechnology-based Drug Delivery Market Challenges
- 5.3.4 Nanotechnology-based Drug Delivery Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Nanotechnology-based Drug Delivery Players by Revenue
- 6.1.1 Global Top Nanotechnology-based Drug Delivery Players by Revenue (2021-2026)
- 6.1.2 Global Nanotechnology-based Drug Delivery Revenue Market Share by Players (2021-2026)
- 6.2 Global Nanotechnology-based Drug Delivery Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Nanotechnology-based Drug Delivery Head Office and Area Served
- 6.4 Global Nanotechnology-based Drug Delivery Players, Product Type & Application
- 6.5 Global Nanotechnology-based Drug Delivery Manufacturers Established Date
- 6.6 Global Nanotechnology-based Drug Delivery Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Nanotechnology-based Drug Delivery Market Size (2021-2032)
- 7.2 North America Nanotechnology-based Drug Delivery Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Nanotechnology-based Drug Delivery Market Size by Country (2021-2026)
- 7.4 North America Nanotechnology-based Drug Delivery Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Nanotechnology-based Drug Delivery Market Size (2021-2032)
- 8.2 Europe Nanotechnology-based Drug Delivery Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Nanotechnology-based Drug Delivery Market Size by Country (2021-2026)
- 8.4 Europe Nanotechnology-based Drug Delivery Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Nanotechnology-based Drug Delivery Market Size (2021-2032)
- 9.2 Asia-Pacific Nanotechnology-based Drug Delivery Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Nanotechnology-based Drug Delivery Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Nanotechnology-based Drug Delivery Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Nanotechnology-based Drug Delivery Market Size (2021-2032)
- 10.2 South America Nanotechnology-based Drug Delivery Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Nanotechnology-based Drug Delivery Market Size by Country (2021-2026)
- 10.4 South America Nanotechnology-based Drug Delivery Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Nanotechnology-based Drug Delivery Market Size (2021-2032)
- 11.2 Middle East & Africa Nanotechnology-based Drug Delivery Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Nanotechnology-based Drug Delivery Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Nanotechnology-based Drug Delivery Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 AbbVie Inc.
- 12.1.1 AbbVie Inc. Company Information
- 12.1.2 AbbVie Inc. Business Overview
- 12.1.3 AbbVie Inc. Revenue in Nanotechnology-based Drug Delivery Business (2021-2026)
- 12.1.4 AbbVie Inc. Nanotechnology-based Drug Delivery Product Portfolio
- 12.1.5 AbbVie Inc. Recent Developments
- 12.2 BlueWillow Biologics Inc.
- 12.2.1 BlueWillow Biologics Inc. Company Information
- 12.2.2 BlueWillow Biologics Inc. Business Overview
- 12.2.3 BlueWillow Biologics Inc. Revenue in Nanotechnology-based Drug Delivery Business (2021-2026)
- 12.2.4 BlueWillow Biologics Inc. Nanotechnology-based Drug Delivery Product Portfolio
- 12.2.5 BlueWillow Biologics Inc. Recent Developments
- 12.3 Camurus AB
- 12.3.1 Camurus AB Company Information
- 12.3.2 Camurus AB Business Overview
- 12.3.3 Camurus AB Revenue in Nanotechnology-based Drug Delivery Business (2021-2026)
- 12.3.4 Camurus AB Nanotechnology-based Drug Delivery Product Portfolio
- 12.3.5 Camurus AB Recent Developments
- 12.4 Celgene, lnc.
- 12.4.1 Celgene, lnc. Company Information
- 12.4.2 Celgene, lnc. Business Overview
- 12.4.3 Celgene, lnc. Revenue in Nanotechnology-based Drug Delivery Business (2021-2026)
- 12.4.4 Celgene, lnc. Nanotechnology-based Drug Delivery Product Portfolio
- 12.4.5 Celgene, lnc. Recent Developments
- 12.5 Cristal Therapeutics
- 12.5.1 Cristal Therapeutics Company Information
- 12.5.2 Cristal Therapeutics Business Overview
- 12.5.3 Cristal Therapeutics Revenue in Nanotechnology-based Drug Delivery Business (2021-2026)
- 12.5.4 Cristal Therapeutics Nanotechnology-based Drug Delivery Product Portfolio
- 12.5.5 Cristal Therapeutics Recent Developments
- 12.6 EyePoint Pharmaceuticals
- 12.6.1 EyePoint Pharmaceuticals Company Information
- 12.6.2 EyePoint Pharmaceuticals Business Overview
- 12.6.3 EyePoint Pharmaceuticals Revenue in Nanotechnology-based Drug Delivery Business (2021-2026)
- 12.6.4 EyePoint Pharmaceuticals Nanotechnology-based Drug Delivery Product Portfolio
- 12.6.5 EyePoint Pharmaceuticals Recent Developments
- 12.7 Johnson and Johnson
- 12.7.1 Johnson and Johnson Company Information
- 12.7.2 Johnson and Johnson Business Overview
- 12.7.3 Johnson and Johnson Revenue in Nanotechnology-based Drug Delivery Business (2021-2026)
- 12.7.4 Johnson and Johnson Nanotechnology-based Drug Delivery Product Portfolio
- 12.7.5 Johnson and Johnson Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst